Section Arrow
Quote
XTNT.NYSE-M
- Xtant Medical Holdings
Quotes are at least 15-min delayed:2026/03/09 19:28 EDT
After Hours
Last
 0.627
0 (0.00%)
Bid
0.62
Ask
0.689
High 0.627 
Low 0.627 
Volume 0 
Regular Hours (Closed)
Last
 0.627
+0.007 (+1.13%)
Day High 
0.65 
Prev. Close
0.62 
1-M High
0.677 
Volume 
113.16K 
Bid
0.62
Ask
0.689
Day Low
0.6007 
Open
0.6284 
1-M Low
0.55 
Market Cap 
86.80M 
Currency 美元 
P/E 62 
%Yield -- 
10-SMA 0.59 
20-SMA 0.59 
50-SMA 0.64 
52-W High 0.95 
52-W Low 0.3401 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
0.01/-0.30
Enterprise Value
109.05M
Balance Sheet
Book Value Per Share
0.36
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
117.27M
Operating Revenue Per Share
0.49
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
After Hours 112.4 -0.25 -0.22%
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
After Hours 71.9 0 0.00%
MDTMedtronic plc91.34+0.44+0.48%25.39PE
After Hours 91.25 -0.09 -0.10%
BFLYButterfly Network3.76+0.11+3.01%-- 
After Hours 3.7 -0.06 -1.60%
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
After Hours 1.3997 +0.0097 +0.70%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products includeOsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.